The NCCN Guidelines recognize MammaPrint to identify patients with breast cancer who may benefit from anthracycline
An analysis of outcomes from a cohort of 1,261 patients from the prospective FLEX study [...]
12
Feb
Feb
A milestone in the approach to prostate cancer: a targeted treatment highlights the importance of molecular diagnosis
A new targeted therapy for metastatic castration-resistant prostate cancer (mCRPC), Akeega®, is already funded and [...]
26
Jan
Jan
Talent and collaboration at Unicas Hackathon: united to diagnose rare diseases
Our Head of Neurology, Alba Navarro, PhD, took part in an initiative that brought together [...]
18
Nov
Nov
Towards More Responsible Genomics: Health in Code Sustainability Report 2024
October 24, 2025. At the Health in Code Group, we understand that our commitment [...]
24
Oct
Oct
Driving Proteomics: Health in Code, Certified Service Provider for Olink Reveal
Proteomics is the branch of biology that studies the complete set of proteins produced by [...]
20
Oct
Oct
A study led by Health in Code cardiologists reveals the key role of intermediate-effect variants in hypertrophic cardiomyopathy
Published in the journal Circulation and led by Dr. Soledad García-Hernández as first author and [...]
02
Sep
Sep
